Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
SXTP
60 Degrees Pharmaceuticals, Inc.
CAPPED RATING
60 Degrees Pharmaceuticals, Inc. (SXTP) is rated C- (2.1/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B-); its weakest is Momentum (D).
Quantitative Factor Evaluation • Updated
Overall Rating
2.1
/ 5.0
C-
Value
B-
Factor Score
3.0
/ 5.0
Growth
C
Factor Score
2.2
/ 5.0
Profitability
D
Factor Score
1.2
/ 5.0
Momentum
D
Factor Score
1.2
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
-0.1
EV / EBITDA
-1.2
Rev Growth YoY
-32.5%
Gross Margin
N/M
Price Return 3M
-52.0%
Price Return 12M
-89.5%
Catalyst Signal
0.00
Market Cap
$1.8M
TTM Revenue
$1.2M
Price / Sales
1.5
ROE
-332.9%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-15 | B- (3.0) | C (2.2) | D (1.2) | D (1.2) | C+ (2.6) | C- (2.1) |
| 2026-11-08 | B- (3.0) | C (2.2) | D (1.3) | D (1.3) | C+ (2.6) | C- (2.1) |
| 2026-11-01 | B- (3.0) | C (2.2) | D (1.4) | C- (2.0) | C+ (2.7) | C (2.2) |
| 2026-10-25 | B- (3.0) | C (2.2) | D (1.3) | D (1.2) | C+ (2.6) | C- (2.1) |
| 2026-10-18 | B- (3.0) | C (2.2) | D (1.3) | D- (1.1) | C+ (2.6) | C- (2.0) |
Page
1
of
4